Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss, including amounts attributable to noncontrolling interest	$ (42,613)	$ (104,107)
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation expense	91,221	78,698
Change in fair value of acquisition related contingent consideration	3,750	0
Charitable donation of common stock	5,914	5,350
Amortization of intangible assets	3,420	1,125
Depreciation expense	1,681	2,206
Amortization of deferred contract acquisition costs	22,946	20,619
Loss from equity method investment	0	2,108
Net amortization of premiums or discounts on short-term investments	(9,141)	(8,494)
Unrealized foreign exchange loss (gain), net	(258)	825
Other non-cash expense (income), net	301	(103)
Changes in assets and liabilities:
Accounts receivable	1,225	25,281
Prepaid expenses and other current assets	13,271	(4,248)
Deferred contract acquisition costs	(20,955)	(18,137)
Other non-current assets	(497)	(721)
Accounts payable	1,350	(1,023)
Accrued expenses and other current liabilities	(21,633)	1,183
Accrued compensation and benefits	(6,902)	2,611
Deferred revenue	14,838	11,175
Other non-current liabilities	(8,083)	1,800
Net cash provided by operating activities	49,835	16,148
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of short-term investments	(263,258)	(334,996)
Proceeds from maturities of short-term investments	376,099	272,984
Purchases of property and equipment	(1,551)	(533)
Payments for business combination, net of cash acquired	(20,210)	0
Payments for asset acquisition	(7,314)	0
Escrow payment related to business combination, after acquisition date	0	(2,500)
Other investing activities	457	0
Net cash provided by (used in) investing activities	84,223	(65,045)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases	10,073	17,777
Issuance of common stock under employee stock purchase plan	7,932	7,751
Net cash provided by financing activities	18,005	25,528
Impact of foreign exchange on cash and cash equivalents	(1,443)	(1,308)
Net increase (decrease) in cash and cash equivalents	150,620	(24,677)
Cash and cash equivalents at beginning of period	287,996	297,902
Cash and cash equivalents at end of period	438,616	273,225
Supplemental disclosure of cash flow information:
Cash paid for income taxes	1,803	4,187
Supplemental disclosure of non-cash investing and financing activities:
Vesting of early exercised stock options	189	809
Unpaid property and equipment in accrued expenses	87	0
Unpaid direct transaction costs related to the asset acquisition in accrued expenses	$ 346	$ 0